Suppression of TNBC Metastasis by Doxazosin, a Novel Dual Inhibitor of C-MET/EGFR

The effect of doxazosin on TNBC cell lines in vitro was evaluated in terms of cell viability, apoptosis, c-MET/EGFR signaling pathway, molecular docking studies and impact on cancer stem cell-like properties.